Durham, NC, United States · North America
OncologyRare diseaseCell & gene therapyVaccines
FDAEMAPMDANMPA
SCALE 270 studies
Open to sponsorsSterile / advanced-therapy specialistView OncologyVaccinesRare disease
NMPAFDAEMAPMDA
SCALE 270 studies
Open to sponsorsSterile / advanced-therapy specialistView OncologyVaccines
PMDAFDAEMANMPA
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView Princeton, NJ, United States · United States
OncologyInfectious diseaseVaccines
FDAEMAMHRAHealth Canada
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView M
Cincinnati, OH, United States · United States
OncologyRare disease
FDAEMAMHRA
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView OncologyCell & gene therapy
NMPAFDAEMAMHRA
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView Morrisville, NC, United States · United States
OncologyRare disease
FDAEMAPMDAMHRA
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView Oncology
EMAFDAMHRA
SCALE 240 studies
Open to sponsorsSelectiveView Oncology
PMDANMPAFDA
SCALE 260 studies
Open to sponsorsSelectiveView Oncology
FDANMPA
SCALE 220 studies
Open to sponsorsSelectiveView Oncology
PMDA
SCALE 200 studies
Open to sponsorsGeneral clinicalView Oncology
PMDAFDA
SCALE 120 studies
Open to sponsorsGeneral clinicalView Company states expertise across oncologycardiologynephrologyurology
SCALE 190 studies
Open to sponsorsGeneral clinicalView